Johnson Johnson Cost Of Revenue Over Time
| JNJ Stock | USD 155.01 0.39 0.25% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Johnson Johnson Performance and Johnson Johnson Correlation. Johnson |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.89) | Dividend Share 4.86 | Earnings Share 6.05 | Revenue Per Share 36.428 | Quarterly Revenue Growth 0.052 |
The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Cost Of Revenue Analysis
Compare Johnson Johnson and related stocks such as Crinetics Pharmaceuticals, Enanta Pharmaceuticals, and Amicus Therapeutics Cost Of Revenue Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRNX | 5.1 M | 5.1 M | 5.1 M | 5.1 M | 5.1 M | 5.1 M | 5.1 M | 9.2 M | 24.5 M | 41.5 M | 57 M | 1.3 M | 1.4 M | 1.1 M | 1 M |
| ENTA | 16.1 M | 20.2 M | 22.8 M | 28.8 M | 36.1 M | 55.8 M | 76.1 M | 115.8 M | 3 M | 3 M | 3 M | 3 M | 2.4 M | 2.7 M | 2.6 M |
| FOLD | 4.6 M | 24.2 M | 20.4 M | 13.6 M | 22.4 M | 41.1 M | 833 K | 6.2 M | 14.4 M | 22 M | 31 M | 34.5 M | 38.6 M | 37.3 M | 21.6 M |
| CNTB | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 1 M | 988 K | 807.5 K |
| LGND | 24.7 M | 4.9 M | 3.6 M | 5.7 M | 9.1 M | 5.8 M | 5.6 M | 5.4 M | 6.3 M | 11.3 M | 30.4 M | 62.2 M | 52.8 M | 35 M | 19.3 M |
| PASG | 134 K | 134 K | 134 K | 134 K | 134 K | 134 K | 134 K | 134 K | 134 K | 134 K | 800 K | 1.5 M | 3.7 M | 3.7 M | 2.2 M |
| ORIC | 1000 K | 1000 K | 1000 K | 1000 K | 1000 K | 1000 K | 1000 K | 1000 K | 1000 K | 1000 K | 970 K | 897 K | 966 K | 1 M | 1.1 M |
| LYEL | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | 14.5 M | 16.5 M | 20.2 M | 16.1 M |
| DSGN | 1.7 K | 1.7 K | 1.7 K | 1.7 K | 1.7 K | 1.7 K | 1.7 K | 1.7 K | 1.7 K | 1.7 K | 5 K | 129 K | 466 K | 537 K | 563.9 K |
| RVMD | 26.6 M | 26.6 M | 26.6 M | 26.6 M | 26.6 M | 26.6 M | 26.6 M | 26.6 M | 50.3 M | 91.8 M | 132.3 M | 7.3 M | 9.7 M | 411.2 M | 431.8 M |
Johnson Johnson and related stocks such as Crinetics Pharmaceuticals, Enanta Pharmaceuticals, and Amicus Therapeutics Cost Of Revenue description
Cost of Revenue is found on Johnson Johnson income statement and represents the costs associated with goods and services Johnson Johnson provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.My Equities
My Current Equities and Potential Positions
| Johnson Johnson | JNJ |
| Classification | Corona Opportunity |
| Location | New Jersey; U.S.A |
| Exchange | New York Stock Exchange |
USD 155.01
Check out Johnson Johnson Performance and Johnson Johnson Correlation. For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Johnson Johnson technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.